Company profile for Avenacy

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

Avenacy is a worldwide pharmaceutical company with its headquarters located in Schaumburg, IL. Our primary focus is on the development, manufacturing, and distribution of essential medications crucial for treating patients across diverse healthcare settings. These settings range from acute care hospitals to outpatient clinics and physician offices throughout the United States. Employing a meticulous and streamlined selection p...
Avenacy is a worldwide pharmaceutical company with its headquarters located in Schaumburg, IL. Our primary focus is on the development, manufacturing, and distribution of essential medications crucial for treating patients across diverse healthcare settings. These settings range from acute care hospitals to outpatient clinics and physician offices throughout the United States. Employing a meticulous and streamlined selection process, we are actively expanding our portfolio by incorporating high-quality FDA-approved products.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
U.S.A
Address
Address
Schaumburg, IL 60173
Telephone
Telephone
youtube
YouTube
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

Default Event

DDL Conference

Not Confirmed

envelop Contact Supplier

DDL Conference

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.businesswire.com/news/home/20251022335884/en/Avenacy-to-Highlight-2025-Achievements-and-Partnership-Opportunities-at-CPHI-Frankfurt

BUSINESSWIRE
22 Oct 2025

https://www.pharmiweb.com/press-release/2025-08-25/avenacy-announces-launch-of-lidocaine-hydrochloride-injection-usp-in-the-us-market

PHARMAWEB
25 Aug 2025

https://www.businesswire.com/news/home/20250721261120/en/Avenacy-Announces-Launch-of-Dehydrated-Alcohol-Injection-USP-Vials-in-the-U.S.-Market

BUSINESSWIRE
21 Jul 2025

https://www.businesswire.com/news/home/20250624957707/en/Avenacy-Announces-New-Asset-Based-Lending-Agreement-with-Texas-Capital-Bank

BUSINESSWIRE
24 Jun 2025

https://www.businesswire.com/news/home/20250602341378/en/Avenacy-Announces-Launch-of-Leuprolide-Acetate-Injection-in-the-U.S.-Market

BUSINESSWIRE
02 Jun 2025

https://www.businesswire.com/news/home/20250527129972/en/Avenacy-Announces-Launch-of-Doxycycline-for-Injection-USP-in-the-U.S.-Market

BUSINESSWIRE
27 May 2025

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty